Cargando…
Should oxidosqualene cyclase in the cholesterol biosynthetic pathway be considered an anti-cancer target?
Autores principales: | SH, Slight, SM, Hyder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792840/ https://www.ncbi.nlm.nih.gov/pubmed/36582466 http://dx.doi.org/10.3389/fcell.2022.1081151 |
Ejemplares similares
-
THU542 Inhibiting Oxidosqualene Cyclase Suppresses Cancer Stem-like Cells And Growth Of Epithelial Ovarian Cancer Cells In Vitro And In Vivo
por: Liang, Yayun, et al.
Publicado: (2023) -
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
por: Maione, Federica, et al.
Publicado: (2015) -
Identification of a novel multifunctional oxidosqualene cyclase from Zea mays sheds light on the biosynthetic pathway of three pentacyclic triterpenoids
por: Fan, Zhenjun, et al.
Publicado: (2022) -
Multiple unbiased approaches identify oxidosqualene cyclase as the molecular target of a promising anti-leishmanial
por: Paradela, Luciana S., et al.
Publicado: (2021) -
Cloning of oxidosqualene cyclases from Maytenus ilicifolia for synthetic biology
por: Barbosa, Cristina C, et al.
Publicado: (2014)